Lemonade LMND
- Market cap
- $3.5B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 3.6×
- Revenue, 12 months
- $975M
- +62% on a year ago
- Net margin
- −14.2%
Lemonade trades at 3.6× sales. Its trailing earnings are negative, so it has no PE. Revenue was $975M over the last twelve months, up 62% on a year earlier with a −14% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $114.5M+55% | $115.5M+31% | $119.1M+25% | $122M+17% | $136.6M+19% | $148.8M+29% | $151.2M+27% | $164.1M+35% | $194.5M+42% | $228.1M+53% | $258M+71% | $294.4M+79% | |
| R&D | $21.8M+2% | $21.1M−10% | $20.9M−4% | $21.2M−12% | $21.9M+1% | $21.8M+3% | $22M+5% | $22.4M+6% | $24.7M+13% | $24.8M+14% | $26.9M+22% | $30M+34% |
| SG&A | $61.3M−20% | $53.5M−8% | $60.2M−1% | $66.6M+20% | $82.8M+35% | $81.2M+52% | $79.1M+31% | $85.4M+28% | $92.4M+12% | $107.3M+32% | $108.3M+37% | $125.5M+47% |
| Pre-tax income | −$59.6M−33% | −$39.6M−42% | −$45.2M−30% | −$55.1M−16% | −$65.8M+10% | −$37.8M−5% | −$61.4M+36% | −$42.6M−23% | −$36.3M−45% | −$20.6M−46% | −$34.6M−44% | −$41.8M−2% |
| $1.9M−17% | $2.8M | $2.1M+91% | $2.1M+62% | $1.9M+0% | −$7.8M | $1M−52% | $1.3M−38% | $1.2M−37% | $1.1M | $1.2M+20% | $1.6M+23% | |
| Net income | −$61.5M−33% | −$42.4M−33% | −$47.3M−28% | −$57.2M−15% | −$67.7M+10% | −$30M−29% | −$62.4M+32% | −$43.9M−23% | −$37.5M−45% | −$21.7M−28% | −$35.8M−43% | −$43.4M−1% |
| −$0.88−36% | −$0.61−34% | −$0.67−30% | −$0.81−17% | −$0.95+8% | −$0.42−31% | −$0.86+28% | −$0.60−26% | −$0.51−46% | −$0.29−31% | −$0.47−45% | −$0.56−7% | |
| 69.8M+4% | 70M+1% | 70.3M+1% | 70.7M+2% | 71.1M+2% | 71.9M+3% | 72.9M+4% | 73.4M+4% | 74.2M+4% | 75.2M+5% | 76.3M+5% | 77M+5% |
Revenue: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
R&D: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
SG&A: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Income tax: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Net income: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
EPS, diluted: 8 periods, Q1 FY19 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY19: share-days: the 6-month average less the second quarter's. 7 periods, Q4 FY19 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Insurance - Property & Casualty nearest Lemonade's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| LMNDLemonade | $3.5B | n/m | n/a | 3.6× | +62% | −14.2% | |
| SLDESlide Insurance | $3.3B | 7.0× | 5.2× | 2.4× | +41% | 40.0% | |
| PLMRPalomar | $3.7B | 19.1× | 27.5× | 3.4× | +60% | 18.6% | |
| SPNTSiriusPoint | $3B | 6.5× | 9.0× | 0.9× | +23% | 15.6% | |
| SKWDSkyward Specialty Insurance | $2.7B | 14.1× | 14.6× | 1.5× | +38% | 10.8% | |
| HCIHCI | $2.5B | 8.8× | 15.6× | 2.7× | +23% | 32.6% | |
| HGHamilton Insurance | $2.4B | 5.9× | 5.4× | 0.8× | +15% | 28.8% | |
| WTMWhite Mountains Insurance | $5.3B | 5.1× | 8.3× | 1.4× | +55% | 29.3% | |
| MCYMercury General | $5.7B | 6.1× | 12.8× | 0.9× | +10% | 14.8% | |
| SIGISelective Insurance | $5.7B | 11.6× | 18.3× | 1.0× | +4% | 9.4% | |
| RLIRLI | $5.9B | 15.1× | 21.6× | 3.1× | +5% | 20.3% | |
| Peer median | $3.5B | 7.9× | 13.7× | 1.5× | +23% | 19.5% |
Investors who own it
Investors we follow who held Lemonade at the end of Jun 30, 2026, from their 13F filings.
- Baillie GiffordBaillie Gifford0.2% of portfoliotrimmed
More on Lemonade
Each number over time
Where it ranks
Its groups
About
- Industry
- Insurance - Property & Casualty
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .